Trastuzumab- and Fab′ fragment-modified curcumin PEG-PLGA nanoparticles: preparation and evaluation in vitro and in vivo
Dongyu Duan,1,* Aiping Wang,1,* Ling Ni,2 Liping Zhang,1 Xiuju Yan,1 Ying Jiang,1 Hongjie Mu,1 Zimei Wu,1 Kaoxiang Sun,1 Youxin Li1,2 1School of Pharmacy, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Key Laboratory of Molecular Phar...
Enregistré dans:
Auteurs principaux: | Duan D, Wang A, Ni L, Zhang L, Yan X, Jiang Y, Mu H, Wu Z, Sun K, Li Y |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/88974bc7fbb946cda3d1d1be33ff2a79 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Leucemia Aguda Infantil en la Xª Región Clasificación FAB y Factores Epidemiológicos
par: Zolezzi R,Paola, et autres
Publié: (1985) -
Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson’s disease treatment
par: Bi CC, et autres
Publié: (2016) -
Reversible cardiotoxicity in a 54-year-old woman treated with trastuzumab
par: Martins,Sandro José, et autres
Publié: (2012) -
Functionalized immunostimulating complexes with protein A via lipid vinyl sulfones to deliver cancer drugs to trastuzumab-resistant HER2-overexpressing breast cancer cells
par: Rodríguez-Serrano F, et autres
Publié: (2016) -
Review of Curcumin Physicochemical Targeting Delivery System
par: Li L, et autres
Publié: (2020)